Cell Medx Corp. (PC) (CMXC) (CMXC): Very typical numbers for a development-s...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Cell Medx Corp. (PC) (CMXC) (CMXC)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	0
Posts	2
Boards Moderated	0
Alias Born	06/13/2021

Re: Boonwolf post# 127

Sunday, 06/13/2021 6:51:15 PM

Sunday, June 13, 2021 6:51:15 PM

Very typical numbers for a development-stage biotech company waiting for approvals. Health Canada came gave its approval first, next is FDA. The stock will rip when that happens. The stock has been well managed and has loyal loyal long-term players who hold the big positions. Microcurrent therapy could reverse the effects of type 2 diabetes. This little company is on to something big. It's my favorite microcap by far.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent CMXC News

Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 03/06/2024 09:49:24 PM
Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 02/22/2024 09:38:37 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/22/2024 05:48:50 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 10:01:14 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 11:08:43 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 08:29:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 08:36:07 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 08:27:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 05:02:47 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/16/2023 09:20:06 PM
Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 09/07/2023 09:00:48 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/01/2023 09:18:25 PM
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 08/29/2023 09:20:38 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/29/2023 09:10:35 PM

More CMXC News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow